TRULANCE

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Jan 19, 2017

   9 yr 7 mo ago

2. Today

3. Patent 7041786 expires

   Listed drug substance patent expiration.

   Jan 30, 2028

   in 1 yr 8 mo

4. Patent 9610321 expires

   Listed method-of-use patent (U-1999) expiration.

   Sep 15, 2031

   in 5 yr 4 mo

5. Patent 9610321 expires

   Listed method-of-use patent (U-2230) expiration.

   Sep 15, 2031

   in 5 yr 4 mo

6. Patent 9919024 expires

   Listed method-of-use patent (U-2230) expiration.

   Sep 15, 2031

   in 5 yr 4 mo

7. Patent 9919024 expires

   Listed method-of-use patent (U-1999) expiration.

   Sep 15, 2031

   in 5 yr 4 mo

8. Patent 9925231 expires

   Listed drug product patent expiration.

   Sep 15, 2031

   in 5 yr 4 mo

9. Patent 11319346 expires

   Listed drug product patent expiration.

   Mar 01, 2032

   in 5 yr 9 mo

10. Patent 9616097 expires

    Listed drug product patent expiration.

    Aug 20, 2032

    in 6 yr 3 mo

11. Patent 10011637 expires

    Listed drug substance patent expiration.

    Jun 05, 2034

    in 8 yr 1 mo

12. Patent 11142549 expires

    Listed drug product patent expiration.

    Jun 05, 2034

    in 8 yr 1 mo

13. Patent 11834521 expires

    Listed drug product patent expiration.

    Jun 05, 2034

    in 8 yr 1 mo

14. Patent 12146003 expires

    Listed drug product patent expiration.

    Jun 05, 2034

    in 8 yr 1 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (12)